399 related articles for article (PubMed ID: 14500639)
1. IL-2-activated CD8+CD44high cells express both adaptive and innate immune system receptors and demonstrate specificity for syngeneic tumor cells.
Dhanji S; Teh HS
J Immunol; 2003 Oct; 171(7):3442-50. PubMed ID: 14500639
[TBL] [Abstract][Full Text] [Related]
2. Selective bystander proliferation of memory CD4+ and CD8+ T cells upon NK T or T cell activation.
Eberl G; Brawand P; MacDonald HR
J Immunol; 2000 Oct; 165(8):4305-11. PubMed ID: 11035065
[TBL] [Abstract][Full Text] [Related]
3. Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo.
Wiemann K; Mittrücker HW; Feger U; Welte SA; Yokoyama WM; Spies T; Rammensee HG; Steinle A
J Immunol; 2005 Jul; 175(2):720-9. PubMed ID: 16002667
[TBL] [Abstract][Full Text] [Related]
4. Differential in vivo persistence of two subsets of memory phenotype CD8 T cells defined by CD44 and CD122 expression levels.
Walzer T; Arpin C; Beloeil L; Marvel J
J Immunol; 2002 Mar; 168(6):2704-11. PubMed ID: 11884436
[TBL] [Abstract][Full Text] [Related]
5. Cutting edge: the NK cell receptor 2B4 augments antigen-specific T cell cytotoxicity through CD48 ligation on neighboring T cells.
Lee KM; Bhawan S; Majima T; Wei H; Nishimura MI; Yagita H; Kumar V
J Immunol; 2003 May; 170(10):4881-5. PubMed ID: 12734329
[TBL] [Abstract][Full Text] [Related]
6. IL-15 promotes the survival of naive and memory phenotype CD8+ T cells.
Berard M; Brandt K; Bulfone-Paus S; Tough DF
J Immunol; 2003 May; 170(10):5018-26. PubMed ID: 12734346
[TBL] [Abstract][Full Text] [Related]
7. IL-21 down-regulates NKG2D/DAP10 expression on human NK and CD8+ T cells.
Burgess SJ; Marusina AI; Pathmanathan I; Borrego F; Coligan JE
J Immunol; 2006 Feb; 176(3):1490-7. PubMed ID: 16424177
[TBL] [Abstract][Full Text] [Related]
8. Self-reactive memory-phenotype CD8 T cells exhibit both MHC-restricted and non-MHC-restricted cytotoxicity: a role for the T-cell receptor and natural killer cell receptors.
Dhanji S; Teh SJ; Oble D; Priatel JJ; Teh HS
Blood; 2004 Oct; 104(7):2116-23. PubMed ID: 15178577
[TBL] [Abstract][Full Text] [Related]
9. Suppressor of cytokine signaling 1 regulates IL-15 receptor signaling in CD8+CD44high memory T lymphocytes.
Ilangumaran S; Ramanathan S; La Rose J; Poussier P; Rottapel R
J Immunol; 2003 Sep; 171(5):2435-45. PubMed ID: 12928391
[TBL] [Abstract][Full Text] [Related]
10. The low affinity Fc receptor for IgG functions as an effective cytolytic receptor for self-specific CD8 T cells.
Dhanji S; Tse K; Teh HS
J Immunol; 2005 Feb; 174(3):1253-8. PubMed ID: 15661880
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of killer cell lectin-like receptor G1 expression on T cells.
Robbins SH; Terrizzi SC; Sydora BC; Mikayama T; Brossay L
J Immunol; 2003 Jun; 170(12):5876-85. PubMed ID: 12794113
[TBL] [Abstract][Full Text] [Related]
12. Constitutive expression of a chimeric receptor that delivers IL-2/IL-15 signals allows antigen-independent proliferation of CD8+CD44high but not other T cells.
Gasser S; Corthésy P; Beerman F; MacDonald HR; Nabholz M
J Immunol; 2000 Jun; 164(11):5659-67. PubMed ID: 10820241
[TBL] [Abstract][Full Text] [Related]
13. Emergence of CD8+ T cells expressing NK cell receptors in influenza A virus-infected mice.
Kambayashi T; Assarsson E; Michaëlsson J; Berglund P; Diehl AD; Chambers BJ; Ljunggren HG
J Immunol; 2000 Nov; 165(9):4964-9. PubMed ID: 11046023
[TBL] [Abstract][Full Text] [Related]
14. Evidence of a novel IL-2/15R beta-targeted cytokine involved in homeostatic proliferation of memory CD8+ T cells.
Kamimura D; Ueda N; Sawa Y; Hachida S; Atsumi T; Nakagawa T; Sawa S; Jin GH; Suzuki H; Ishihara K; Murakami M; Hirano T
J Immunol; 2004 Nov; 173(10):6041-9. PubMed ID: 15528339
[TBL] [Abstract][Full Text] [Related]
15. Cytolytic mechanisms and expression of activation-regulating receptors on effector-type CD8+CD45RA+CD27- human T cells.
Baars PA; Ribeiro Do Couto LM; Leusen JH; Hooibrink B; Kuijpers TW; Lens SM; van Lier RA
J Immunol; 2000 Aug; 165(4):1910-7. PubMed ID: 10925272
[TBL] [Abstract][Full Text] [Related]
16. In vivo antitumor activity of NKT cells activated by the combination of IL-12 and IL-18.
Baxevanis CN; Gritzapis AD; Papamichail M
J Immunol; 2003 Sep; 171(6):2953-9. PubMed ID: 12960319
[TBL] [Abstract][Full Text] [Related]
17. A novel mechanism of antitumor response involving the expansion of CD3+/CD56+ large granular lymphocytes triggered by a tumor-expressed activating ligand.
Costello RT; Sivori S; Mallet F; Sainty D; Arnoulet C; Reviron D; Gastaut JA; Moretta A; Olive D
Leukemia; 2002 May; 16(5):855-60. PubMed ID: 11986947
[TBL] [Abstract][Full Text] [Related]
18. Functional similarity and differences between selection-independent CD4-CD8- alphabeta T cells and positively selected CD8 T cells expressing the same TCR and the induction of anergy in CD4-CD8- alphabeta T cells in antigen-expressing mice.
Caveno J; Zhang Y; Motyka B; Teh SJ; Teh HS
J Immunol; 1999 Aug; 163(3):1222-9. PubMed ID: 10415017
[TBL] [Abstract][Full Text] [Related]
19. Memory phenotype of CD8+ T cells in MHC class Ia-deficient mice.
Kurepa Z; Su J; Forman J
J Immunol; 2003 Jun; 170(11):5414-20. PubMed ID: 12759416
[TBL] [Abstract][Full Text] [Related]
20. Preassociation of IL-15 with IL-15R alpha-IgG1-Fc enhances its activity on proliferation of NK and CD8+/CD44high T cells and its antitumor action.
Dubois S; Patel HJ; Zhang M; Waldmann TA; Müller JR
J Immunol; 2008 Feb; 180(4):2099-106. PubMed ID: 18250415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
